
DNAmito's proprietary DNA technology and cloud platform deliver personalized radiation therapy that targets tumors with unprecedented accuracy while sparing healthy tissue.
DNAmito's team of genomics experts and data scientists work to transform cancer care by combining proprietary DNA technology with open industry standards. We're committed to delivering scalable solutions that improve clinical outcomes and streamline treatment across institutions.

DNAmito enables precise cancer treatment through its proprietary DNA technology and cloud platform. Our technology leverage existing and open standards in the industry. DNAmito is vendor agnostic.
DNAmito is a leading provider of precise radiation treatment for cancer through proprietary DNA technology and a vendor-agnostic cloud platform.